NT-3 involvement in autoimmune articular symptoms is indicated by its presence in the synovial fluid of patients with spondyloarthritis [64] and by increased levels in the sera of systemic sclerosis patients with articular complications that require hydroxychloroquine treatment [36]. Here, NTF3 is linked to systemic sclerosis.